Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study

As the COVID-19 pandemic continues to spread, the number of associated deaths continues to increase, especially among those with pre-existing conditions. Azvudine is recommended as a priority treatment for patients with COVID-19, but its efficacy in patients with pre-existing conditions is unknown....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	EClinicalMedicine 2023-05, Vol.59, p.101981-101981, Article 101981
Hauptverfasser:	Sun, Yuming, Jin, Liping, Dian, Yating, Shen, Minxue, Zeng, Furong, Chen, Xiang, Deng, Guangtong
Format:	Artikel
Sprache:	eng
Schlagworte:	All-cause death Azvudine Composite disease progression outcome COVID-19 Pre-existing conditions Real-world
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!